Chengdu Kanghua Biological Products Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 990.06 million compared to CNY 1,054.55 million a year ago. Revenue was CNY 990.06 million compared to CNY 1,054.55 million a year ago.

Net income was CNY 368.94 million compared to CNY 483.31 million a year ago. Basic earnings per share from continuing operations was CNY 2.7584 compared to CNY 3.6067 a year ago. Diluted earnings per share from continuing operations was CNY 2.758 compared to CNY 3.6067 a year ago.